Stem Cell Based Therapies for Blindness: David Hinton – CIRM Science Writer’s Seminar – Video
(Part 6 of 9) David Hinton, Ph.D., spoke at the Scientific Writer's Seminar, a workshop presented on September 17, 2008 at CIRM headquarters in San Francisco. Hinton has a CIRM grant to study the therapeutic potential of retinal pigment epithelial cell lines derived from human embryonic stem cells for retinal degeneration. Hinton is a professor of pathology, neurosurgery, and ophthalmology at the Keck School of Medicine at the University of Southern California.
View post:
Stem Cell Based Therapies for Blindness: David Hinton - CIRM Science Writer's Seminar - Video